Drugmakers Find Much To Love In Final FDA Reform Bill

Law360, New York (June 19, 2012, 9:24 PM ET) -- The U.S. House of Representatives is expected to vote Wednesday on a final version of the Food and Drug Administration user fee bill, which has been stripped of controversy but will still largely benefit the industry, with provisions extending exclusivity for certain drugs and directing the FDA to accept foreign clinical data and issue a comprehensive social media policy.

Three weeks of negotiations to reconcile the House and Senate versions of the bill stripped the legislation of controversy, including an industry-backed proposal to create a nationwide...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required